FDA warns about meningitis risk associated with GSK's Lamictal

08/12/2010 | Google

The FDA warned that GlaxoSmithKline's anti-seizure drug Lamictal might cause aseptic meningitis, an inflammation of the brain, after the agency received reports of 40 cases of the adverse effect between 1994 and 2009. The agency said it will include a warning about the risk on the drug's label.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ